These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29733425)

  • 1. Economics meets healthcare: how can it be useful?
    Barros PP
    Eur J Cardiothorac Surg; 2018 Jul; 54(1):1-3. PubMed ID: 29733425
    [No Abstract]   [Full Text] [Related]  

  • 2. Should cost considerations be included in medical decisions? No.
    Du B; Kahn JM
    Intensive Care Med; 2015 Oct; 41(10):1841-3. PubMed ID: 26215679
    [No Abstract]   [Full Text] [Related]  

  • 3. Should cost considerations be included in medical decisions? Yes.
    Guidet B; Beale R
    Intensive Care Med; 2015 Oct; 41(10):1838-40. PubMed ID: 26215681
    [No Abstract]   [Full Text] [Related]  

  • 4. 'Health Economics' and the evolution of economic evaluation of health technologies.
    Hutton J
    Health Econ; 2012 Jan; 21(1):13-8. PubMed ID: 22147623
    [No Abstract]   [Full Text] [Related]  

  • 5. Healthcare technology, economics, and policy: an evolving balance.
    Kern SE; Jaron D
    IEEE Eng Med Biol Mag; 2003; 22(1):16-9. PubMed ID: 12683057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost/benefit analysis-another dimension.
    Hess OW
    Med Instrum; 1982; 16(1):76-7. PubMed ID: 6801445
    [No Abstract]   [Full Text] [Related]  

  • 7. Health economics of care for patients with cancer and intractable disease in Japan.
    Hisashige A; Katayama T; Mikasa H
    Support Care Cancer; 1998 Nov; 6(6):503-10. PubMed ID: 9833298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an alternative to quality-adjusted life years for supporting healthcare decision making?
    Beresniak A; Dupont D
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):351-7. PubMed ID: 27139424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concept of Combining Cost-Effectiveness Analysis and Budget Impact Analysis in Health Care Decision-Making.
    Yagudina RI; Kulikov AU; Serpik VG; Ugrekhelidze DT
    Value Health Reg Issues; 2017 Sep; 13():61-66. PubMed ID: 29073991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing value in health care programs.
    Volpp KG; Loewenstein G; Asch DA
    JAMA; 2012 May; 307(20):2153-4. PubMed ID: 22618919
    [No Abstract]   [Full Text] [Related]  

  • 11. Health economics: a beginner's guide.
    Thornton JG
    Br J Hosp Med; 1997 Dec; 58(11):547-50. PubMed ID: 10193467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health economics as the basis for the synthesis of efficiency and financial soundness in statutory health insurance].
    Straub C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):73-80. PubMed ID: 16333646
    [No Abstract]   [Full Text] [Related]  

  • 13. A scoping review of health economic evaluation in the World Health Organization Eastern Mediterranean region.
    Sharkawy MN; Dastan I
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):877-884. PubMed ID: 34024232
    [No Abstract]   [Full Text] [Related]  

  • 14. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could or Should We Use MCDA in the French HTA Process?
    Ghabri S; Josselin JM; Le Maux B
    Pharmacoeconomics; 2019 Dec; 37(12):1417-1419. PubMed ID: 31565761
    [No Abstract]   [Full Text] [Related]  

  • 16. [Health economics of psychological diseases].
    König HH; Friemel S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):46-56. PubMed ID: 16362133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing inter-sectoral costs and benefits of interventions in the healthcare sector: methods for obtaining unit prices.
    Drost RM; Paulus AT; Ruwaard D; Evers SM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Feb; 17(1):77-84. PubMed ID: 26757960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspects of economic evaluation in health care].
    Noelle G; Jaskulla E; Sawicki PT
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):28-33. PubMed ID: 16341607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One size does not always fit all in value assessment.
    Basu A; Grieve R; Pritchard D; Stevens W
    Am J Manag Care; 2019 Nov; 25(11):540-542. PubMed ID: 31747231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the anesthesiologist in the wider governance of healthcare and health economics.
    Martin J; Cheng D
    Can J Anaesth; 2013 Sep; 60(9):918-28. PubMed ID: 23820969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.